VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 179 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $322,963 | -34.4% | 74,760 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $492,668 | -2.9% | 74,760 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $507,620 | +29.7% | 74,760 | +41.2% | 0.00% | 0.0% |
Q4 2022 | $391,374 | +31.3% | 52,960 | +75.6% | 0.00% | 0.0% |
Q3 2022 | $298,000 | -9.4% | 30,160 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $329,000 | -3.5% | 30,160 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $341,000 | -27.9% | 30,160 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $473,000 | -48.2% | 30,160 | -43.4% | 0.00% | -50.0% |
Q3 2021 | $914,000 | -20.2% | 53,300 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $1,146,000 | +43.1% | 53,300 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $801,000 | +14.4% | 53,300 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $700,000 | +35.9% | 53,300 | 0.0% | 0.00% | +100.0% |
Q3 2020 | $515,000 | -15.6% | 53,300 | 0.0% | 0.00% | -50.0% |
Q2 2020 | $610,000 | +10.5% | 53,300 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $552,000 | -28.1% | 53,300 | +13.9% | 0.00% | 0.0% |
Q4 2019 | $768,000 | – | 46,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 2,491,200 | $27,154,000 | 2.37% |
Profit Investment Management, LLC | 281,890 | $3,071,000 | 2.26% |
Sio Capital Management, LLC | 488,965 | $5,330,000 | 2.00% |
Zebra Capital Management LLC | 14,766 | $161,000 | 0.47% |
Prairiewood Capital, LLC | 50,165 | $547,000 | 0.43% |
TANG CAPITAL MANAGEMENT LLC | 256,696 | $2,798,000 | 0.42% |
HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $1,700,000 | 0.29% |
GLOBEFLEX CAPITAL L P | 100,843 | $1,099,000 | 0.27% |
Epoch Investment Partners, Inc. | 2,757,646 | $30,059,000 | 0.18% |
EMC Capital Management | 16,185 | $176,000 | 0.15% |